https://iecure.com/wp-content/uploads/insider.svg52280Emily Hennes/wp-content/uploads/iEcure_logo.pngEmily Hennes2021-12-01 19:30:422021-12-30 12:41:0634 healthcare and biotech startups that are set to take off in 2022, according to top investors
https://iecure.com/wp-content/uploads/logo-tm.svg52280Emily Hennes/wp-content/uploads/iEcure_logo.pngEmily Hennes2021-12-01 19:29:062021-12-29 20:47:04Penn gene editing spinout iECURE just raised a $50M Series A
https://iecure.com/wp-content/uploads/forbes_logo_white.svg50198David Anderson/wp-content/uploads/iEcure_logo.pngDavid Anderson2021-09-09 08:00:322022-02-04 18:51:00This Startup Just Raised $50 Million To Deliver Gene Therapies For Rare Diseases
https://iecure.com/wp-content/uploads/logo-MedCity.svg52280Emily Hennes/wp-content/uploads/iEcure_logo.pngEmily Hennes2021-12-01 19:29:522021-12-29 20:44:37Genetic meds pioneer James Wilson has a new startup, this time in gene editing
https://iecure.com/wp-content/uploads/cen-logo.svg52280Emily Hennes/wp-content/uploads/iEcure_logo.pngEmily Hennes2021-12-01 19:26:302021-12-29 21:00:35Jim Wilson launches liver disease gene-editing company iECURE with $50 million
https://iecure.com/wp-content/uploads/logo-fiercebiotech.svg52280Emily Hennes/wp-content/uploads/iEcure_logo.pngEmily Hennes2021-12-01 19:25:272021-12-29 21:02:46iECURE emerges with $50M to search for ‘holy grail’ and ‘untapped frontier’ of gene editing
https://iecure.com/wp-content/uploads/endpoint-news.svg52280Emily Hennes/wp-content/uploads/iEcure_logo.pngEmily Hennes2021-09-09 08:00:552021-12-30 15:38:36The Tachi Yamada legacy tree continues to grow with a new gene editing biotech from Jim Wilson
